Dermatology
NICE Guideline: Human and animal bites. Assessment, indications for antibiotic prophylaxis in uninfected bites, and choice of antibiotic are reviewed
5 Nov, 2020 | 09:02h | UTC
Systemic treatments for eczema: A network meta‐analysis
4 Oct, 2020 | 22:45h | UTCSystemic treatments for eczema: a network meta‐analysis – Cochrane Library
Understanding necrotizing soft tissue infections in the intensive care unit
25 Sep, 2020 | 02:31h | UTC
Commentary on Twitter
Necrotizing soft tissue infections in #ICU, focus on optimizing interventions most likely to impact outcome:
➡️ keep high index of suspicion vs misdiagnosis/delays in starting treatment
➡️ coordinate urgent approach: early debridement + broad-spectrum ABThttps://t.co/NpkxYFHbGl pic.twitter.com/8LDQuOGobI— Intens Care Med (@yourICM) September 22, 2020
JAMA Network Series: Medical Specialties and the COVID-19 Pandemic
24 Sep, 2020 | 09:45h | UTCEditorial: The COVID-19 Pandemic and the JAMA Network
See articles:
- Cardiology and COVID-19
- Dermatology and COVID-19
- Internal Medicine and COVID-19
- Nephrology and COVID-19
- Neurology and COVID-19
- Oncology and COVID-19
- Ophthalmology and COVID-19
- Otolaryngology–Head and Neck Surgery and COVID-19
- Pediatrics and COVID-19
- Psychiatry and COVID-19
- Surgery and COVID-19
- JAMA Network Open and COVID-19
- JAMA Health Forum and COVID-19
NICE Guideline: Antimicrobial prescribing for insect bites and stings
23 Sep, 2020 | 14:40h | UTC
Multisystem effects of COVID-19: A concise review for practitioners
16 Sep, 2020 | 09:14h | UTCMultisystem effects of COVID-19: A concise review for practitioners – Postgraduate Medicine
Systematic review: Interventions for American cutaneous and mucocutaneous leishmaniasis
16 Sep, 2020 | 08:47h | UTCInterventions for American cutaneous and mucocutaneous leishmaniasis – Cochrane Library
Commentary on Twitter
Interventions for American cutaneous and mucocutaneous leishmaniasis https://t.co/3DFXrAUOEc Updated systematic review includes 75 studies with 6533 randomised participants. #ACML is a disfiguring disease caused by parasites, transmitted to humans by sandflies. @CochraneMoss
— The Cochrane Library (@CochraneLibrary) September 15, 2020
Cutaneous manifestations of COVID-19: An evidence-based review
15 Sep, 2020 | 08:55h | UTC
8 ways the coronavirus can affect your skin, from COVID toes, to rashes and hair loss
24 Aug, 2020 | 00:35h | UTC
Maculopapular eruptions associated with COVID ‐19
19 Aug, 2020 | 09:29h | UTC
[Abstract Only] Meta-analysis: Point-of-care ultrasonography for the diagnosis of skin and soft tissue abscesses
3 Aug, 2020 | 01:18h | UTCPoint-of-Care Ultrasonography for the Diagnosis of Skin and Soft Tissue Abscesses: A Systematic Review and Meta-analysis – Annals of Emergency Medicine (link to abstract – $ for full-text)
Commentary: POCUS for Abscess – A Large Meta-Analysis – Journal Feed
[Abstract Only] Trial of Roflumilast cream for chronic plaque psoriasis
16 Jul, 2020 | 08:15h | UTCTrial of Roflumilast Cream for Chronic Plaque Psoriasis – New England Journal of Medicine
Commentary: Researchers discover that topical treatment improves chronic plaque psoriasis – Mount Sinai Hospital
Review: Extrapulmonary Manifestations of COVID-19
13 Jul, 2020 | 00:28h | UTCExtrapulmonary manifestations of COVID-19 – Nature Medicine
Related review: Extra‐pulmonary complications of COVID‐19: a multi‐system disease? – Journal of Medical Virology
[Abstract Only] Randomized Trial: Ruxolitinib Cream for Treatment of Vitiligo
12 Jul, 2020 | 23:58h | UTCRuxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial – The Lancet
Related Commentary on Twitter
NEW—Treatment with ruxolitinib cream was associated with substantial repigmentation of vitiligo lesions up to 52 weeks of treatment, and all doses were well tolerated: finding from a randomised, controlled, phase 2 trial https://t.co/Td5nlsMcYI pic.twitter.com/CHvtspGstQ
— The Lancet (@TheLancet) July 10, 2020
Study Supports Link Between COVID-19 and ‘COVID Toes’
3 Jul, 2020 | 08:34h | UTCNews Release: Study supports link between COVID-19 and ‘COVID Toes’ – Wiley
Randomized Trial: Atezolizumab, Vemurafenib, and Cobimetinib for Advanced BRAFV600 Mutation-positive Melanoma
16 Jun, 2020 | 07:48h | UTC
Cohort Study: Fexofenadine use During Pregnancy Does Not Appear to Be Associated with Increased Risk of Adverse Fetal Outcomes
3 Jun, 2020 | 03:31h | UTCAssociation Between Fexofenadine Use During Pregnancy and Fetal Outcomes – JAMA Pediatrics (free for a limited period)
German Guidelines for the Diagnosis and Treatment of Perianal Dermatitis
1 Jun, 2020 | 03:49h | UTC
EULAR Recommendations for the Management of Psoriatic Arthritis
28 May, 2020 | 09:31h | UTCEditorial: EULAR PsA management recommendations 2019: can the recommendations be improved?
Commentary: EULAR releases recommendations for PsA management – Medicine Matters
Study: Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients
26 May, 2020 | 09:43h | UTC
Classification of the Cutaneous Manifestations of COVID‐19 with 375 Illustrative Cases
1 May, 2020 | 03:43h | UTCRelated: Journal articles on coronavirus with relevance for skin diseases and dermatology – Centre of Evidence Based Dermatology, University of Nottingham AND Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak – Journal of the American Academy of Dermatology
Great atlas with the different cutaneous manifestations of Covid-19.
Case Series: Characterization of Ischemic Cutaneous Lesions Associated with Covid-19
29 Apr, 2020 | 05:14h | UTCSee also: Journal articles on coronavirus with relevance for skin diseases and dermatology – Centre of Evidence Based Dermatology, University of Nottingham AND From ‘COVID Toes’ to Hives, These Are the Skin Conditions Dermatologists Think Could Be Signs of Coronavirus – TIME
ASCO Guideline: Systemic Therapy for Melanoma
3 Apr, 2020 | 03:57h | UTCSystemic Therapy for Melanoma: ASCO Guideline – Journal of Clinical Oncology
Randomized Trial: Treatment of Advanced AIDS-associated Kaposi Sarcoma in Resource-limited Settings
8 Mar, 2020 | 20:16h | UTC
FDA Safety Alert: Montelukast May Cause Serious Mental Health Side Effects
6 Mar, 2020 | 10:22h | UTCCommentary: Montelukast to Get Boxed Warning – NEJM Journal Watch (free)